Tuesday 19 January 2016

CBD source in the EU

http://www.satipharm.com/

3 comments:

  1. In this article it is suggested that “the inclusion of HSP inhibitors in CBD treatment regimens can enhance the overall effect.” http://www.ncbi.nlm.nih.gov/pubmed/26504004 I am not qualified to evaluate the validity of this claim, but perhaps it is worth considering.

    Very best,
    Thomas

    ReplyDelete
    Replies
    1. HSP inhibitors are under development for cancer uses, though to my knowledge none are approved yet.

      http://www.syntapharma.com/pipeline-ganetespib.php

      Delete
  2. The company also deliveres to the US and Israel.

    ReplyDelete